共 50 条
- [1] Use of Sodium-Glucose Transport Protein 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors in Patients with MASLD in a Real-World Setting is Associated with Lower All-Cause Mortality AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1231 - S1232
- [3] Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: A meta-analysis of randomized controlled trials DIABETES OBESITY & METABOLISM, 2021, 23 (04): : 1052 - 1056
- [4] Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5420 - 5430
- [6] Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (11): : 1774 - 1780
- [10] Association of Cholecystectomy, Risk of Gastrointestinal Cancers, and All-Cause Mortality in Patients with Gallstones: A Multi-Center Research Network AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S56 - S57